Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

NCT02593942 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Supratentorial Neoplasms

Interventions

DRUG: Remifentanil
DRUG: Propofol

Sponsor

Yeditepe University Hospital